ADVM - Adverum Biotechnologies, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 10.43

Open

$ 10.35

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 10.35 - $ 10.70

52 Week Range

$ 7.40 - $ 29.70

Volume

900,529

Average Volume

Market Cap

105.16M

Beta (5Y Monthly)

$ 1.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-18-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-30-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-29-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-01-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-28-2020	03-31-2020	10-Q
17	03-12-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	03-06-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-08-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-06-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-09-2017	12-31-2016	10-K
30	11-08-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-06-2016	03-31-2016	10-Q
33	03-04-2016	12-31-2015	10-K
34	11-09-2015	09-30-2015	10-Q
35	08-13-2015	06-30-2015	10-Q
36	05-13-2015	03-31-2015	10-Q
37	03-05-2015	12-31-2014	10-K
38	11-12-2014	09-30-2014	10-Q
39	09-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Initiates Coverage On ...
04/30/2024 10:09:10

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Buy rati...

Mizuho Maintains Buy on Adverum Biotechnol...
04/29/2024 11:33:34

Mizuho analyst Graig Suvannavejh maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and lowers the price target from...

Adverum Biotechnologies To Present LUNA 26...
04/25/2024 20:40:03

Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of c...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 20:31:12

Trading Halt: Halt status updated at 8:55:...
03/21/2024 12:55:04

Trading Halt: Halted at 7:50:00 p.m. ET - ...
03/20/2024 23:50:04

why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Lifecore Biomedical Shares Are Trading...
03/20/2024 18:03:46

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

Chardan Capital Reiterates Buy on Adverum ...
03/19/2024 12:54:13

Chardan Capital analyst Daniil Gataulin reiterates Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and maintains $4 price t...

RBC Capital Maintains Sector Perform on Ad...
03/19/2024 12:13:42

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Sector Perform and lowers the price tar...

Adverum Biotechnologies Announces 1-For-10...
03/18/2024 20:10:31

Approval of 1-for-10 reverse stock split: On March 8, the Board of Directors approved a 1-for-10 reverse stock split of the Com...

Adverum Biotechnologies Q4 EPS $(0.23) Bea...
03/18/2024 20:09:48

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate ...

why-is-blindness-focused-adverum-biotechnologies-stock-trading-lower-today

Why Is Blindness Focused-Adverum Biotechno...
02/08/2024 19:59:21

Adverum Biotechnologies' Ixo-vec gene therapy for wet AMD. Preliminary LUNA Phase 2 trial data show safety, efficacy, and s...

Adverum Biotechnologies Announced Prelimin...
02/08/2024 12:15:29

Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including tr...

Mizuho Maintains Buy on Adverum Biotechnol...
02/06/2024 19:16:45

Mizuho analyst Graig Suvannavejh maintains Adverum Biotechnologies (NASDAQ:ADVM) with a Buy and raises the price target from...

why-air-products-and-chemicals-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Air Products and Chemicals Shares Are ...
02/05/2024 17:56:50

Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-th...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
02/05/2024 17:31:04

why-adverum-biotechnologies-stock-is-trading-higher

Why Adverum Biotechnologies Stock Is Tradi...
02/05/2024 15:50:22

Adverum will sell the shares at a price per share of $1.20, representing a premium of approximately 20% to its stock's 30-d...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
02/05/2024 13:06:14

Adverum Biotechnologies Has Agreed To Sell...
02/05/2024 12:48:08

Adverum Biotechnologies To Present LUNA Pr...
12/07/2023 21:18:45

Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of ...